Aerie to Acquire Dry Eye Disease-Focused Pharma Avizorex
Aerie Pharmaceuticals - Crunchbase Company Profile & Funding
AERIE PHARMACEUTICALS, INC. NPS 2022
Alcon Buys Aerie Pharma For $770M To Enhance Its Ophthalmic Pharma Portfolio
Aerie Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update | Business Wire
Aerie Pharmaceutical (AERI) Stock Rises on FDA Approval
Aerie Pharmaceuticals Inc - For Investor Use Important Information The information in this presentation does not contain all of the information that a potential investor should review before investing in Aerie shares.
Aerie Pharmaceuticals Inc - For Investor Use Important Information The information in this presentation does not contain all of the information that a potential investor should review before investing in Aerie shares.
Aerie Pharmaceuticals - Positive Rhopressa Launch May Mark The Stock Price Peak (NASDAQ:AERI) | Seeking Alpha